Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people finish their first pen of Wegovy without a single bout of nausea. No side effects at all — at least none they notice. That is genuinely possible, and it does not mean the medicine is not working. Wegovy (semaglutide) is a prescription-only medicine that must be assessed and prescribed by a qualified clinician before you start. For most people, side effects on Wegovy are mild and temporary; for a minority, they are barely perceptible. Understanding what the evidence actually says (rather than assuming the worst or assuming you are immune) is the most useful thing you can do before or during treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception our prescribers hear most often. The assumption seems logical (a medicine this potent must produce some sign it is doing something) but the clinical picture is more straightforward than that.
Wegovy works by activating GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetite signals. That mechanism does not require you to feel sick. Weight loss in the STEP 1 trial (published in the New England Journal of Medicine) averaged around 15% of body weight over 68 weeks at the 2.4mg maintenance dose. Participants who tolerated the titration well (few or no GI complaints) still achieved meaningful weight loss. The medicine was working; their bodies had simply adapted quietly.
Tolerance varies substantially from person to person. Genetics, baseline gut motility, how carefully the dose is titrated, and even what you eat during the first weeks all influence how a body responds. Having no side effects on Wegovy does not warrant asking for a faster dose increase or second-guessing whether treatment is effective. The prescriber-led titration schedule exists for good reasons, and side-effect absence is not one of the reasons to deviate from it.
If you want a fuller picture of the range of reported effects, our overview of the five most commonly reported Wegovy side effects covers what the trial data and NHS guidance say in more detail.
The NHS medicines page for semaglutide lists the most common side effects as nausea, vomiting, diarrhoea, constipation, indigestion, burping, fatigue, headache, dizziness and injection-site reactions. These are categorised as common or very common, meaning they occur in more than one in ten people taking the medicine, but that also means a proportion of people do not experience them at all.
Gut symptoms tend to cluster around dose increases rather than persisting at a steady level. The titration schedule (0.25mg rising gradually to the 2.4mg maintenance dose over several months) is specifically designed to give the body time to adjust. People who eat smaller portions, avoid high-fat meals and stay well hydrated during the early weeks generally report fewer and shorter episodes. Our page on what to eat on Wegovy to avoid feeling sick covers this in practical terms.
Side effects at the higher dose are not inevitable either. Some patients move through the full titration to 2.4mg (or, for those now on the newer 7.2mg single-dose pen approved by the MHRA in April 2026) without reporting significant problems. That is not unusual enough to be alarming; it is one end of a recognised spectrum.
The pattern of side effects over time matters too. How long symptoms typically last, and why some persist longer than others, is explored in our piece on how long Wegovy side effects last.
Tolerating Wegovy well most of the time is not a reason to ignore new or unusual symptoms. Several side effects require prompt attention, and knowing them in advance is simply practical.
Seek urgent medical help if you develop severe stomach pain that radiates to your back, with or without vomiting, this can be a sign of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting pancreatitis as a known but infrequent serious side effect of GLP-1 medicines. The pain is typically persistent and significantly different from ordinary nausea.
Other signs that warrant calling 111 or your GP promptly: symptoms of gallbladder problems (severe pain in the upper right abdomen, particularly after eating), signs of serious dehydration from prolonged vomiting or diarrhoea, symptoms of an allergic reaction (swelling of the face or throat, difficulty breathing, a widespread rash), or sudden changes to your vision. If you experience thoughts of self-harm or notice a significant shift in your mood, contact a healthcare professional or call 116 123 (Samaritans) without delay.
You can report any suspected side effect (or flag a suspect seller) through the MHRA's Yellow Card scheme. Reports from patients taking medicines like Wegovy help regulators monitor the real-world safety picture, and they are genuinely useful.
If you are unsure whether what you are experiencing is expected, a quick message to our aftercare team (available seven days a week) is always an option. The contact page has all the details.
Wegovy is a prescription-only medicine, and the clinical assessment before prescribing it covers far more than a BMI check. At nume, a GPhC-registered Independent Prescriber (a named clinician, not an automated system) reads every consultation the same day it is submitted. That review includes your medical history, current medicines, any conditions that affect suitability, and the specific factors that can make side effects more or less likely for you.
If you are already on Wegovy through another provider and considering a transfer, or if you have questions about what side effects from Wegovy might mean for you specifically, bringing those questions to the consultation is exactly what it is for. Some patients find it reassuring to know that the absence of side effects has already been discussed and is already expected.
You can read more about the treatment itself (how it works, who it is licensed for, and how the dose journey unfolds) on our Wegovy treatment page. If cost is on your mind as you decide, the Wegovy pricing page sets out what is included in a single transparent price. And if you are ready to talk to a clinician, starting a free consultation is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.